Djordje Atanackovic MD
Associate Professor, Internal Medicine, University of Utah Sch of Med
Join to View Full Profile
655 W. Baltimore StreetBaltimore, MD 21201
Phone+1 410-706-1946
Fax+1 410-328-6559
Dr. Atanackovic is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Freie University Berlin Faculty of MedicineClass of 1998
Certifications & Licensure
MD State Medical License 2020 - 2026
UT State Medical License 2013 - 2026
Publications & Presentations
PubMed
- Lifileucel (AMTAGVI) tumor-infiltrating lymphocyte morphology in CellaVision peripheral smear reviews.Laura M Wake, Rima Koka, Ariel A Fromowitz, Petr F Hausner, Aaron P Rapoport
Journal of Hematopathology. 2025-03-26 - Universal driving restrictions beyond 4 weeks appear unnecessary following CAR-T therapy in multiple myeloma.Rahul Banerjee, Alicia Richards, Shonali Midha, Aimaz Afrough, Faiz Anwer
Blood Advances. 2025-03-15 - 1 citationsComparison of Standard-of-Care Idecabtagene Vicleucel and Ciltacabtagene Autoleucel in Relapsed/Refractory Multiple Myeloma.Doris K Hansen, Lauren C Peres, Danai Dima, Alicia Richards, Leyla Shune
Journal of Clinical Oncology. 2025-02-18
Abstracts/Posters
- B Cell Maturation Antigen-Specific CAR T Cells for Relapsed or Refractory Multiple Myeloma: A Meta-AnalysisDjordje Atanackovic, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- B Cell Maturation Antigen-Specific CAR T Cells for Relapsed or Refractory Multiple Myeloma: A Meta-AnalysisDjordje Atanackovic, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Press Mentions
University of Maryland Greenebaum Comprehensive Cancer Center Offers Novel Next-Generation CAR T-cell Therapy for B-cell Lymphomas in First-in-Human Clinical TrialNovember 25th, 2024- New Cancer Treatment Changing Outlook for Those with Blood CancersJuly 11th, 2022
- COVID Vaccine Protection May Be Weaker in Some Cancer Patients. But Experts Say They Should Still Get VaccinatedMay 17th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
